Woodline Partners LP

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in ARQT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,594,977

-$1,068,781 QoQ

Shares Held

195,033

0.0% QoQ

Ownership

0.156%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,320,901,631 across 188 Biotechnology names. ARQT ranks #115 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
5	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
6	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
7	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750
8	CYTK	Cytokinetics Inc	1,000,428	$65,938,209

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,594,977	195,033	0.0%	Shares	Sole	2026-05-15
2025-12-31	$5,663,758	195,033	-38.0%	Shares	Sole	2026-02-17
2025-09-30	$5,930,568	314,619	+53.1%	Shares	Sole	2025-11-14
2025-06-30	$2,881,250	205,510	-49.9%	Shares	Sole	2025-08-14
2025-03-31	$6,412,400	410,000	-62.9%	Shares	Sole	2025-05-15
2023-09-30	$5,863,535	1,104,244	+36.7%	Shares	Sole	2023-11-14
2023-06-30	$7,697,857	807,750	+16.1%	Shares	Sole	2023-08-14
2023-03-31	$7,652,425	695,675	+7.9%	Shares	Sole	2023-05-15
2022-12-31	$9,544,505	644,899	+17.2%	Shares	Sole	2023-02-14
2022-09-30	$10,518,067	550,396	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.